Treatment of COVID-19
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F22%3A10451167" target="_blank" >RIV/00216208:11310/22:10451167 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/22:10451167
Result on the web
<a href="https://patentcenter.uspto.gov/applications/17235437" target="_blank" >https://patentcenter.uspto.gov/applications/17235437</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Treatment of COVID-19
Original language description
In certain aspects, disclosed herein is a method of preventing Acute Respiratory Distress Syndrome (ARDS) in a subject, the method comprising administering bazedoxifene to the subject. In some embodiments, the subject has COVID-19. In some embodiments, the subject is at risk of a cytokine storm. In some embodiments, administering the bazedoxifene prevents initiation of a cytokine storm. In some embodiments, administering the bazedoxifene reduces the severity of a cytokine storm. In some embodiments, administering the bazedoxifene reduces the level of IL-6 signaling in the subject.In certain aspects, disclosed herein is a method of preventing a cytokine storm in a subject, the method comprising administering bazedoxifene to the subject. In some embodiments, the subject has COVID-19. In some embodiments, administering the bazedoxifene reduces the level of IL-6 signaling in the subject.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10607 - Virology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
US 11,246,874 B1
Publisher
US001 -
Publisher name
United States Patent and Trademark Office (USPTO)
Place of publication
Alexandria
Publication country
US - UNITED STATES
Date of acceptance
Feb 15, 2022
Owner name
Univerzita Karlova
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence